All posts by detrich

Global Fund Notifies Countries on 2017-2019 Allocations

For the 2017-2019 allocation period, the Global Fund adopted a refined allocation methodology to deliver the aims of its 2017-2022 strategy and to increase the impact of country programs that prevent, treat and care for people affected by HIV, TB...

/ 21 December 2016

The Global Fund has a new Sustainability, Transition, and Co-financing Policy

Which means that for the next allocation period, the Global Fund will proactively support sustainability and transition planning, especially for upper middle income countries (UMICs) and low middle income countries (LMICs) with low or moderate disease burdens. Download the new...

/ 6 December 2016

Middle East and North Africa Position Statement on HIV/AIDS to the High-Level Meeting on AIDS

Middle East and North Africa Position Statement on HIV/AIDS to the UN General Assembly Special Session High-Level Meeting on AIDS 6 – 8 June 2016 We, the undersigned communities of the MENA region; regional an d national networks and civil...

/ 7 April 2016

Civil Society Calls on WHO to Include Report from UN’s High Level Panel on Medicines on WHO Board Agenda

Dear Director General Dr. Margaret Chan Request to include discussion of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines at the next WHO Board meeting As members of the Make Medicines Affordable campaign, and other Civil...

/ 28 February 2016

Launch of the MENA Regional Platform on Global Fund and Civil Society

The Global Fund in the MENA region The Global Fund against AIDS, Tuberculosis and Malaria (GFATM) is the largest financing institution that supports government and civil society in their response to HIV, TB and malaria in the Middle East and...

/ 12 January 2016

WHO Launches New HIV Treatment and Prevention Guidelines

The WHO has made two important new treatment recommendations that will affect all HIV treatment programmes. The recommendations are entitled the ’Early Release’ Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. The recommendations in this...

/ 14 October 2015